Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products. An InPharma commentary
Loading...
Author (Corporation)
Publication date
01.09.2023
Typ of student thesis
Course of study
Collections
Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
European Journal of Pharmaceutical Sciences
Special issue
DOI of the original publication
Link
Series
Series number
Volume
188
Issue / Number
Pages / Duration
Patent number
Publisher / Publishing institution
Elsevier
Place of publication / Event location
Edition
Version
Programming language
Assignee
Practice partner / Client
Keywords
Subject (DDC)
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
0928-0987
1879-0720
1879-0720
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Published
Review
Peer review of the complete publication
Open access category
Gold
Citation
Reppas, C., Kuentz, M., Bauer-Brandl, A., Carlert, S., Dallmann, A., Dietrich, S., Dressman, J., Ejskjaer, L., Frechen, S., Guidetti, M., Holm, R., Holzem, F. L., Karlsson, Ε., Kostewicz, E., Panbachi, S., Paulus, F., Senniksen, M. B., Stillhart, C., Turner, D. B., et al. (2023). Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products. An InPharma commentary. European Journal of Pharmaceutical Sciences, 188. https://doi.org/10.1016/j.ejps.2023.106505